EYPT vs KEY · rev $43.3M vs P/E 13, rev $7.51B
Eyepoint Pharmaceuticals Inc (EYPT) versus KeyCorp (KEY) — a side-by-side from cached financials, not a winner call.
Eyepoint Pharmaceuticals Inc (EYPT) is a biotechnology company listed on NASDAQ.
KeyCorp (KEY) is a banks - regional company listed on US.
Latest reported EYPT revenue for 2024-12-31 was $43.3M. Net income was -$130.9M. Revenue was down 6.0% from 2023-12-31 to 2024-12-31. EYPT currently screens at market cap $1.10B.
Latest reported KEY revenue for 2025-12-31 was $7.51B. Net income was $1.83B. Revenue was up 62.7% from 2024-12-31 to 2025-12-31. KEY currently screens at market cap $22.64B and trailing P/E 12.8.
EYPT currently screens at market cap $1.10B. KEY currently screens at market cap $22.64B and trailing P/E 12.8.
Not investment advice. Open the EYPT and KEY stock pages for the full models.
Not investment advice.